Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_the_private_equity_firm,_Candover_Green_in_2018
|
| gptkbp:awards |
Received multiple industry awards
|
| gptkbp:customerBase |
Serves clients globally
|
| gptkbp:employeeCount |
Approximately 200
|
| gptkbp:focus |
Energy
Industrial Life sciences Telecommunications Consumer products Software_and_digital_solutions |
| gptkbp:founded |
1997
|
| gptkbp:has_expertise_in |
Medical devices
Risk management Software development Supply chain management Clinical trials Prototyping Quality assurance Data analytics Intellectual property management User experience design Regulatory compliance Wearable technology Customer engagement Diagnostics IoT solutions Market analysis Testing and validation Product lifecycle management Technology transfer Brand development Market entry strategy Sales strategy Drug delivery systems Regulatory submissions Partnership development Cybersecurity solutions Manufacturing support Sustainability solutions Innovation strategy Exit strategy Funding strategy Digital_transformation |
| gptkbp:headquarters |
Harston,_Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sagentia Group plc
|
| gptkbp:industry |
Consulting
|
| gptkbp:keyPeople |
gptkb:Dr._David_W._H._Smith
Dr._Andrew_W._H._Smith |
| gptkbp:location |
gptkb:Cambridge
|
| gptkbp:partnerships |
Collaborates with universities
Engages with established companies Works with startups |
| gptkbp:services |
Research and development
Product development Technology consulting |
| gptkbp:subsidiary |
gptkb:Sagentia_Limited
|
| gptkbp:website |
www.sagentia.com
|